NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship

Rehabilitation & Therapy

Discover advanced educational opportunities. Register for an upcoming event or access our past events.

Motivate Patient Compliance and Improve Outcomes

Tracking changes in body composition – fluid, muscle, or fat – provides clinicians insight into disease progression and the ability to optimize treatment plans for success. Actionable data can also motivate patient compliance. Utilizing the SOZO® Digital Health Platform in your clinical practice can greatly improve outcomes and the quality of life for patients.1

Precise Data

Tape measurements are rudimentary and unreliable and cannot distinguish between fluid and tissue gain. SOZO measures and tracks critical patient data.

Actionable Results

Detecting changes in body composition ensures your patients are losing or gaining weight the right way and helps establish healthy targets.

Motivate Patient Compliance

SOZO Device with L-Dex

SOZO® Digital Health Platform

SOZO’s powerful data to aide in the assessment and management of chronic disease delivers:

  • Early Detection – Detect changes and intervene early in the course of a disease
  • Treatment Monitoring – Monitor the impact of therapeutic interventions
  • Patient Education – Motivate patients to comply with treatment
Learn More About SOZO

Rehabilitation & Therapy Solutions


L-Dex Analysis & Lymphedema Prevention Program

Offer your patients peace of mind.

  • Limb lymphedema impacts 1 in 3 at-risk cancer patients2, 3
  • In the largest randomized trial to assess lymphedema prevention in breast cancer patients, 92% of patients with early detection using L-Dex and intervention did not progress to chronic lymphedema1
  • Learn more about ImpediMed’s Lymphedema Prevention Program for early detection and intervention of cancer-related lymphedema utilizing L‑Dex and the Test, Trigger, Treat® protocol

The L-Dex score, only available from ImpediMed, is designed to detect lymphedema-related fluid changes in the limbs.

Learn more about L-Dex

The Lymphedema Prevention Program (LPP) is a comprehensive program for early detection and intervention of cancer-related lymphedema.

Learn more about LPP

BodyComp Analysis

Empower your patients to change habits and take charge of their health.

  • Commonly used metrics such as weight and BMI tell us nothing about body composition
  • Even with a “normal” weight and BMI, a person can have significant health risks
  • Tracking changes in body composition provides insight into disease progression or treatment success and motivates patient compliance

BodyComp Analysis provides a complete fluid, tissue, and metabolic analysis of the human body.

Learn more about BodyComp Analysis

ImpediMed SOZO BodyComp Analysis Comprehensive Analysis

Segmental BodyComp Analysis

Inspire your patients to care for their whole self.

  • Limb volume does not equal limb composition. Two limbs with the same volume can have different composition – fluid, muscle, and fat
  •  Sometimes your focus is on a single limb. Identify asymmetry between left and right limbs
  • A true measure of limb composition is needed to guide treatment decisions and evaluate impact of therapy

Segmental BodyComp Analysis provides a detailed analysis of each arm and each leg.

Learn more about Segmental BodyComp Analysis

ImpediMed SOZO Segmental BodyComp Analysis Detailed Analysis


Final 3-Year Primary Endpoint Results Published

Clinical References

Lymphedema Prevention

A randomized trial, meta-analysis, and six independent studies consistently demonstrate that early detection with L-Dex and intervention reduces progression to chronic cancer-related lymphedema.

L-Dex Validation

L-Dex is validated to detect lymphedema at its earliest, subclinical stage. It can detect fluid shifts as small as 36 mL (2.4 tbsp)4.

L-Dex Economics

Early detection and intervention of cancer-related lymphedema is shown to reduce the cost of care compared to treating advanced lymphedema.

Clinical Practice Guidelines

NCCN Guidelines® recommend patient education and regular monitoring for the early detection of lymphedema.

Learn More

Additional guidelines support early detection and intervention


Rehabilitation & Therapy Resources

Medical Specialty Rehabilitation & Therapy

Prehabilitation Model

Learn how The Ohio State University Comprehensive Breast Center uses a prehabilitation model of care for lymphedema monitoring.

ImpediMed Webinars and Events

Webinars & Events

Check out the latest news about ImpediMed products, technologies, clinical trials, partnerships, and financials.

ImpediMed Software User Guides


ImpediMed Academy training events and webinars are held throughout the year. See what is coming up as well as view past events.


  1. Ridner SH, et al. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention. Lymphatic Research and Biology 2022.
  2. NIH, National Cancer Institute: accessed April 30, 2019.
  3. Shaitelman SF, et al. Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin 2015;65:55-81.
  4. Ward, L. Is BIS ready for prime time as the gold standard measure. Jrn Lymphoedema 2009;4(2)